de Pirro R, Bertoli A, Fusco A, Testa I, Greco A V, Lauro R
J Clin Endocrinol Metab. 1980 Sep;51(3):503-7. doi: 10.1210/jcem-51-3-503.
Results of a recent study suggested that depending upon the glucocorticoid or the model used, opposite changes occur in insulin binding; in fact, the increase in insulin receptor number on monocytes after prednisone ingestion in man appears to contrast with previous reports in animals in which a decrease was shown after dexamethasone. To establish whether this apparent discrepancy depends upon the model used in human studies (i.e. monocytes), the effect of dexamethasone and corticone intake on normal men was evaluated. A significant decrease was observed in insulin binding on circulating monocytes 24, 48, and 72 h after both steroids, mainly due to reduced receptor affinity. Furthermore, steroid treatment increased insulinemia which did not appear to be related to insulin binding. These data are in agreement with results in animal studies and appear to suggest that previous data on prednisone do not depend upon the model used (i.e. monocytes) but upon the hormone itself, thus indicating that glucocorticoids, depending upon their chemical structure, may produce opposite changes in membrane insulin binding sites. Furthermore, since dexamethasone and cortisone affect plasma insulin levels in the same fashion as previously reported with prednisone, it is suggested that the variation in insulin binding observed after glucocorticoid treatment is not due to variations in insulinemia.
最近一项研究的结果表明,根据所使用的糖皮质激素或模型不同,胰岛素结合会出现相反的变化;事实上,人类服用泼尼松后单核细胞上胰岛素受体数量的增加似乎与之前动物研究的报告相反,在动物研究中,地塞米松给药后胰岛素受体数量出现减少。为了确定这种明显的差异是否取决于人体研究中所使用的模型(即单核细胞),评估了地塞米松和皮质酮摄入对正常男性的影响。在两种类固醇给药后24、48和72小时,循环单核细胞上的胰岛素结合显著减少,主要是由于受体亲和力降低。此外,类固醇治疗使胰岛素血症增加,这似乎与胰岛素结合无关。这些数据与动物研究结果一致,似乎表明之前关于泼尼松的数据并不取决于所使用的模型(即单核细胞),而是取决于激素本身,因此表明糖皮质激素根据其化学结构,可能会在膜胰岛素结合位点产生相反的变化。此外,由于地塞米松和可的松对血浆胰岛素水平的影响与之前报道的泼尼松相同,因此提示糖皮质激素治疗后观察到的胰岛素结合变化并非由于胰岛素血症的变化。